XML 25 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:    
Net income $ 10,527,222 $ 8,449,770
Adjustments to reconcile net income to net cash provided by operating activities:    
Accretion of purchase discount (46,088) 0
Amortization of premiums on held-for-investment loans 457,749 0
Accretion of collateralized loan obligations discounts, net 207,767 1,137,156
Amortization of deferred offering costs (32,085) (40,000)
Amortization of deferred financing costs 1,953,465 1,029,899
Realized loss on mortgage servicing rights 10,910 0
Loss on extinguishment of debt 1,663,926 0
Unrealized loss on mortgage servicing rights 356,772 1,780,528
Restricted stock compensation expense 15,608 20,292
Net change in:    
Accrued interest receivable (1,962,135) 326,737
Deferred offering costs 0 40,000
Other assets (55,464) (286,607)
Accrued interest payable 271,119 (372,190)
Fees and expenses payable to Manager 668,802 164,359
Other accounts payable and accrued expenses (190,621) (30,735)
Net cash provided by operating activities 13,846,947 12,219,209
Cash flows from investing activities:    
Purchase of commercial mortgage loans held-for-investment (983,694,326) (57,601,572)
Principal payments from commercial mortgage loans held-for-investment 506,402,705 145,516,658
Net cash (used in) provided by investing activities (477,291,621) 87,915,086
Cash flows from financing activities:    
Proceeds from issuance of common stock 0 5,747,375
Net proceeds from issuance of preferred stock 57,254,935 0
Dividends paid on common stock (9,978,162) (7,638,270)
Dividends paid on preferred stock (2,115,000) (15,000)
Proceeds from collateralized obligations 833,750,000 0
Proceeds from secured term loan 7,500,000 0
Payment of collateralized loan obligations (465,316,126) (44,864,874)
Payment of deferred financing costs (8,747,277) 0
Net cash provided by (used in) financing activities 412,348,370 (46,770,769)
Net (decrease) increase in cash, cash equivalents and restricted cash (51,096,304) 53,363,526
Cash, cash equivalents and restricted cash, beginning of period 69,375,356 16,011,830
Cash, cash equivalents and restricted cash, end of period 18,279,052 69,375,356
Supplemental disclosure of cash flow information    
Cash paid for interest 13,079,740 13,386,816
Cash paid for income taxes 0 180,898
Non-cash investing and financing activities information    
Dividends declared but not paid at end of period $ 3,426,559 $ 3,242,650